We were exceptionally proud to sponsor a session at the ABPI conference last week at such a critical juncture for the UK pharmaceutical industry. The speakers, including Matt Hancock, Dr June Raine and Professor Sir John Bell, provided inspiration and food for thought- we certainly feel optimistic about the future of the UK as a life sciences powerhouse. To read our event summary, click here.
We enjoyed another successful PharmaMedic virtual breakfast briefing on 22nd April focusing on practical insights for consultants. If you missed it, you can catch up on the key takeaways including key questions on latest implications of the changes in IR35 legislation for consultants here. We are also delighted to share the video replay of the event.
PharmaMedic Consultancy is proud to feature as a session sponsor at the virtual ABPI Annual Conference on Thursday, 29 April 2021. The theme of this year's event is "Building a Life Sciences Superpower" – a vision and ambition which we at PharmaMedic wholeheartedly support. Read more about our participation and the event.
More than ever over the last 12 months, our use of patient data has been essential to support public health and gain information about vital medicines. In this article, we interview Dr Sheuli Porkess, Director of Actaros Consultancy for her insights on the latest trends, regulatory adoption and her expectations and hopes for the future.
Following the success of our first virtual breakfast briefing in February 2021, PharmaMedic invites consultants and those thinking of becoming a consultant, to register for our new event on Thursday, April 22nd 2021. Our expert presenters will discuss key issues facing pharmaceutical consultants in 2021- navigating #IR35, establishing your vision and adapting to change. Click here to learn more and register.
We've championed the benefits of outsourced medical affairs solutions for over a decade. During the last 12 months, the skills and experience of our consultants have been needed more than ever to help pharmaceutical clients navigate through the COVID-19 crisis. Read more to learn how.
We enjoyed welcoming delegates to our first virtual breakfast briefing earlier this month discussing the trends shaping medical and regulatory affairs in 2021. In this round-up, we share some of the key discussion points- from a post-Brexit MHRA, to the new ILAP scheme. We look forward to exploring these issues further in future PharmaMedic events soon.
As 2021 gets underway, in the context of continued pandemic response and post-Brexit environment, the role of regulatory affairs in pharma is likely to be more instrumental than ever. In this article, we share a preview of the key regulatory trends that Dr Zubair Hussain will discuss at our upcoming breakfast briefing on the 10th February. Read on to learn more about the ways regulatory affairs is set to underpin innovation and sign up to attend our virtual briefing.
We marked our 5-year anniversary as a client of the London Bioscience Innovation Centre (LBIC) recently and featured in its Winter newsletter alongside Prokarium, MicrosensDx and VirTus and others.
2020 was certainly one of the most unusual years we can recall. Thank you to our clients, consultants and readers for following our news stories. We wrote on a range of topics and we recap the most widely read articles of last year in this short read.
